Crystalline forms of 6-(3-((5-chloro-2-methoxypyridine)-3-sulfonamido)-2,6-difluorophenyl)-n-methylimidazo[1,5-a]pyrazine-1-carboxamide and methods for using the same
AssigneeHiberCell, Inc.
InventorsXiawei JIANG, Pengyuan CHEN
Life of this patent
Estimating the term…
Abstract
Provided herein are crystalline forms of a compound of formula (I) and pharmaceutical compositions thereof. Also provided herein are methods of using the crystalline forms and pharmaceutical compositions to treat a cancer or a neurodegenerative disease in a subject in need thereof.
Claims90
A crystalline potassium salt of a compound of formula (I)
A crystalline hydrate of a potassium salt of a compound of formula (I)
Form I of a potassium salt of a compound of formula (I)
Form II of a potassium salt of a compound of formula (I)
Form III of a potassium salt of a compound of formula (I)
A pharmaceutical composition comprising:
- (i) a crystalline potassium salt of the compound of formula (I)
- and
- (ii) a pharmaceutically acceptable excipient.
A pharmaceutical composition comprising:
- (i) a crystalline hydrate of a potassium salt of a compound of formula (I)
- and
- (ii) a pharmaceutically acceptable excipient.
Dependencies are inferred from the claim text.